drugset / Trial / NCT00809536

Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time

NCT00809536

Phase 1 Terminated 24 enrolled Pfizer
RandomizedCrossoverOpen-label

Summary

1. To estimate the effects of multiple doses of PD 0332334 on the elimination of a single dose of metformin from the body 2. To estimate the effects of multiple doses of metformin on the elimination of a single dose of PD 0332334 from the body 3. To evaluate the safety and tolerability when PD 0332334 and metformin are administered at the same time.

Timeline

Start
2009-01
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject IMAGABALIN Other / unclassified 225 mg Oral
Subject IMAGABALIN Other / unclassified 300 mg Oral
Subject Metformin Small molecule 500 mg Oral